A detailed history of Burney CO transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Burney CO holds 20,947 shares of ALNY stock, worth $5.1 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
20,947
Previous 25,439 17.66%
Holding current value
$5.1 Million
Previous $6.18 Million 6.78%
% of portfolio
0.23%
Previous 0.26%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$233.81 - $287.01 $1.05 Million - $1.29 Million
-4,492 Reduced 17.66%
20,947 $5.76 Million
Q2 2024

Jul 29, 2024

SELL
$143.31 - $247.0 $232,162 - $400,140
-1,620 Reduced 5.99%
25,439 $6.18 Million
Q1 2024

May 22, 2024

BUY
$146.51 - $198.2 $3.12 Million - $4.23 Million
21,325 Added 371.9%
27,059 $4.04 Million
Q4 2023

Feb 12, 2024

BUY
$151.41 - $196.57 $868,184 - $1.13 Million
5,734 New
5,734 $1.1 Million

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $29.9B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Burney CO Portfolio

Follow Burney CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Burney CO, based on Form 13F filings with the SEC.

News

Stay updated on Burney CO with notifications on news.